Pulse Biosciences (PLSE) Cash from Operations Growth (3y) (2018 - 2025)
Pulse Biosciences (PLSE) Cash from Operations Growth (3y) (2018 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Ops. Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 126.74 Bn | 121.52 Bn | 1.96 Bn | 16.81% |
| 2 | Becton Dickinson | 44.89 Bn | 44.07 Bn | 2.15 Bn | 53.64% |
| 3 | Alcon | 33.18 Bn | 31.52 Bn | 1.53 Bn | 70.05% |
| 4 | Medline | 32.90 Bn | 30.67 Bn | 1.84 Bn | - |
| 5 | Resmed | 29.48 Bn | 27.82 Bn | 890.98 Mn | 25.17% |
| 6 | West Pharmaceutical Services | 23.15 Bn | 22.72 Bn | 329.20 Mn | -9.84% |
| 7 | Solventum | 14.12 Bn | 13.55 Bn | 1.10 Bn | -33.35% |
| 8 | Cooper Companies | 13.87 Bn | 13.73 Bn | 735.40 Mn | 13.75% |
| 9 | Align Technology | 12.17 Bn | 11.11 Bn | 736.59 Mn | -8.92% |
| 10 | Pulse Biosciences | 2.20 Bn | 2.12 Bn | - | -22.81% |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -22.81% |
| Sep 30, 2025 | -7.04% |
| Jun 30, 2025 | 0.04% |
| Mar 31, 2025 | 4.64% |
| Dec 31, 2024 | 10.36% |
| Sep 30, 2024 | 12.24% |
| Jun 30, 2024 | 19.95% |
| Mar 31, 2024 | 5.77% |
| Dec 31, 2023 | 9.84% |
| Sep 30, 2023 | -7.05% |
| Jun 30, 2023 | -5.04% |
| Mar 31, 2023 | 11.94% |
| Dec 31, 2022 | 4.68% |
| Sep 30, 2022 | -10.11% |
| Jun 30, 2022 | -9.77% |
| Mar 31, 2022 | -28.61% |
| Dec 31, 2021 | -26.25% |
| Sep 30, 2021 | -24.91% |
| Jun 30, 2021 | -41.97% |
| Mar 31, 2021 | -32.55% |